Effects of Various Cannabinoid Ligands on Choice Behaviour in a Rat Model of Gambling

Overview

Journal Behav Pharmacol

Specialties Pharmacology
Psychology
Social Sciences

Date 2016 Feb 25

PMID 26905189

Citations 7

Authors

Aliou B Gueye

Jose M Trigo

Kiran V Vemuri

Alexandros Makriyannis

Bernard Le Foll

Affiliations

Soon will be listed here.

Abstract

It is estimated that 0.6-1% of the population in the USA and Canada fulfil the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) criteria for gambling disorders (GD). To date, there are no approved pharmacological treatments for GD. The rat gambling task (rGT) is a recently developed rodent analogue of the Iowa gambling task in which rats are trained to associate four response holes with different magnitudes and probabilities of food pellet rewards and punishing time-out periods. Similar to healthy human volunteers, most rats adopt the optimal strategies (optimal group). However, a subset of animals show preference for the disadvantageous options (suboptimal group), mimicking the choice pattern of patients with GD. Here, we explored for the first time the effects of various cannabinoid ligands (WIN 55,212-2, AM 4113, AM 630 and URB 597) on the rGT. Administration of the cannabinoid agonist CB1/CB2 WIN 55,212-2 improved choice strategy and increased choice latency in the suboptimal group, but only increased perseverative behaviour, when punished, in the optimal group. Blockade of CB1 or CB2 receptors or inhibition of fatty-acid amide hydrolase did not affect rGT performance. These results suggest that stimulation of cannabinoid receptors could affect gambling choice behaviours differentially in some subgroups of subjects.

Citing Articles

A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol.

Pallanti S, Marras A, Makris N Front Psychiatry. 2021; 12:634418.

PMID: 34603091 PMC: 8484302. DOI: 10.3389/fpsyt.2021.634418.

Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects.

Braunscheidel K, Okas M, Floresco S, Woodward J Psychopharmacology (Berl). 2021; 239(5):1337-1347.

PMID: 34291308 PMC: 9885490. DOI: 10.1007/s00213-021-05914-8.

The Mouse Gambling Task: Assessing Individual Decision-making Strategies in Mice.

Pittaras E, Rabat A, Granon S Bio Protoc. 2021; 10(1):e3479.

PMID: 33654712 PMC: 7842597. DOI: 10.21769/BioProtoc.3479.

Gambling and Cannabis Use: Clinical and Policy Implications.

Winters K, Whelan J J Gambl Stud. 2019; 36(1):223-241.

PMID: 31828696 DOI: 10.1007/s10899-019-09919-z.

Review: brain neurobiology of gambling disorder based on rodent models.

Quintero Garzola G Neuropsychiatr Dis Treat. 2019; 15:1751-1770.

PMID: 31308669 PMC: 6612953. DOI: 10.2147/NDT.S192746.

References

Pope Jr H, Gruber A, Hudson J, Huestis M, Yurgelun-Todd D . Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001; 58(10):909-15. DOI: 10.1001/archpsyc.58.10.909. View

Lane S, Cherek D, Tcheremissine O, Lieving L, Pietras C . Acute marijuana effects on human risk taking. Neuropsychopharmacology. 2005; 30(4):800-9. DOI: 10.1038/sj.npp.1300620. View

van Gaalen M, Brueggeman R, Bronius P, Schoffelmeer A, Vanderschuren L . Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl). 2006; 187(1):73-85. DOI: 10.1007/s00213-006-0396-1. View

Maldonado R, Valverde O, Berrendero F . Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006; 29(4):225-32. DOI: 10.1016/j.tins.2006.01.008. View

Adamczyk P, McCreary A, Przegalinski E, Mierzejewski P, Bienkowski P, Filip M . The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats. J Physiol Pharmacol. 2009; 60(3):119-25. View

Marco E, Adriani W, Canese R, Podo F, Viveros M, Laviola G . Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats. Pharmacol Biochem Behav. 2006; 86(2):334-45. DOI: 10.1016/j.pbb.2006.10.006. View

Lefever T, Marusich J, Antonazzo K, Wiley J . Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacol Biochem Behav. 2014; 118:30-5. PMC: 3930061. DOI: 10.1016/j.pbb.2014.01.002. View

Alexander Arguello P, Jentsch J . Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. Psychopharmacology (Berl). 2004; 177(1-2):141-50. DOI: 10.1007/s00213-004-1953-0. View

Zeeb F, Robbins T, Winstanley C . Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology. 2009; 34(10):2329-43. DOI: 10.1038/npp.2009.62. View

10.

Zeeb F, Wong A, Winstanley C . Differential effects of environmental enrichment, social-housing, and isolation-rearing on a rat gambling task: dissociations between impulsive action and risky decision-making. Psychopharmacology (Berl). 2012; 225(2):381-95. DOI: 10.1007/s00213-012-2822-x. View

11.

Gamaleddin I, Wertheim C, Zhu A, Coen K, Vemuri K, Makryannis A . Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addict Biol. 2011; 17(1):47-61. DOI: 10.1111/j.1369-1600.2011.00314.x. View

12.

Bolla K, Brown K, Eldreth D, Tate K, Cadet J . Dose-related neurocognitive effects of marijuana use. Neurology. 2002; 59(9):1337-43. DOI: 10.1212/01.wnl.0000031422.66442.49. View

13.

Crystal J, Maxwell K, Hohmann A . Cannabinoid modulation of sensitivity to time. Behav Brain Res. 2003; 144(1-2):57-66. DOI: 10.1016/s0166-4328(03)00062-7. View

14.

Herkenham M . Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci. 1992; 654:19-32. DOI: 10.1111/j.1749-6632.1992.tb25953.x. View

15.

Narayanan N, Land B, Solder J, Deisseroth K, DiLeone R . Prefrontal D1 dopamine signaling is required for temporal control. Proc Natl Acad Sci U S A. 2012; 109(50):20726-31. PMC: 3528521. DOI: 10.1073/pnas.1211258109. View

16.

Egerton A, Allison C, Brett R, Pratt J . Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci Biobehav Rev. 2006; 30(5):680-95. DOI: 10.1016/j.neubiorev.2005.12.002. View

17.

Villella C, Martinotti G, Di Nicola M, Cassano M, La Torre G, Gliubizzi M . Behavioural addictions in adolescents and young adults: results from a prevalence study. J Gambl Stud. 2010; 27(2):203-14. DOI: 10.1007/s10899-010-9206-0. View

18.

Adriani W, Laviola G . Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol. 2004; 15(5-6):341-52. DOI: 10.1097/00008877-200409000-00005. View

19.

de Lago E, de Miguel R, Lastres-Becker I, Ramos J, Fernandez-Ruiz J . Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Res. 2004; 1007(1-2):152-9. DOI: 10.1016/j.brainres.2004.02.016. View

20.

Jayamanne A, Greenwood R, Mitchell V, Aslan S, Piomelli D, Vaughan C . Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol. 2005; 147(3):281-8. PMC: 1751298. DOI: 10.1038/sj.bjp.0706510. View